2-chloroadenosine has been researched along with Myocardial Infarction in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joachim, D; Marquetant, R; Simonis, G; Strasser, RH; Weinbrenner, C; Wiedemann, S | 1 |
Asanuma, H; Fujita, M; Hirata, A; Kim, J; Kitakaze, M; Komamura, K; Minamino, T; Mochizuki, N; Okada, K; Okazaki, H; Seguchi, O; Takashima, S; Tsukamoto, O; Wakeno, M | 1 |
Dubey, RK; Gillespie, DG; Jackson, EK | 1 |
Nakajima, Y; Nakashima, M; Saniabadi, AR; Takeich, S; Umemura, K; Yukawa, N | 1 |
Dubey, RK; Gillespie, DG; Jackson, EK; Mi, Z; Zacharia, LC | 1 |
5 other study(ies) available for 2-chloroadenosine and Myocardial Infarction
Article | Year |
---|---|
Stimulation of adenosine A2b receptors blocks apoptosis in the non-infarcted myocardium even when administered after the onset of infarction.
Topics: 2-Chloroadenosine; Adenosine A2 Receptor Agonists; Animals; Apoptosis; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Treatment Outcome | 2009 |
Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats.
Topics: 2-Chloroadenosine; Acetamides; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Cardiomegaly; Collagen; Fibrosis; Heart Ventricles; Male; Matrix Metalloproteinases; Myocardial Infarction; Myocardium; Purinergic P1 Receptor Antagonists; Purines; Rats; Rats, Wistar; RNA, Messenger; Theophylline; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling | 2006 |
Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors.
Topics: 2-Chloroadenosine; Adenosine; Animals; Cardiovascular Agents; Cell Culture Techniques; Cell Division; Collagen; Fibroblasts; Fibrosis; Heart Ventricles; Male; Myocardial Infarction; Protein Biosynthesis; Proteins; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1 | 1998 |
Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report.
Topics: 2-Chloroadenosine; Adenosine Diphosphate; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Aspirin; Blood Platelets; Cardiovascular Diseases; Cilostazol; Death, Sudden, Cardiac; Disease Susceptibility; Dose-Response Relationship, Drug; Heterozygote; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles | 1998 |
A(2b) receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts.
Topics: 2-Chloroadenosine; Adenosine; Animals; Becaplermin; Cell Division; Cells, Cultured; Collagen; Cyclic AMP; DNA; Enzyme Activation; Fibroblasts; Hypertension; Male; Mitogen-Activated Protein Kinases; Mitogens; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oligonucleotides, Antisense; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1; Signal Transduction | 2001 |